The same nicotine product that's legal in London can get seized at customs in Sydney. Global nicotine regulation isn't converging. It's fragmenting. If you're manufacturing for international markets, you need to know exactly what each country requires before you commit to a formulation, a supplier, or a launch timeline.
United States: PMTA or Nothing
The FDA's Center for Tobacco Products regulates all tobacco and nicotine products under the Family Smoking Prevention and Tobacco Control Act.
- Market authorization: PMTA required for every new tobacco/nicotine product. No PMTA, no legal sales.
- Synthetic nicotine: Regulated since 2022. Congress closed that loophole.
- Documentation bar: Extensive ingredient, manufacturing, and health impact data required. Your nicotine supplier's documentation quality directly affects application strength.
- Enforcement: Warning letters, injunctions, and import detention for unauthorized products.
The US market has the highest documentation requirements of any country. If your supplier can pass PMTA scrutiny, they can likely support submissions anywhere.
European Union: TPD Framework
The Tobacco Products Directive (Directive 2014/40/EU) sets harmonized rules across 27 member states.
- Nicotine limit: 20 mg/mL maximum for consumer e-liquids
- Volume limits: 10 mL refill containers, 2 mL cartridges
- Market entry: 6-month pre-market notification to each member state
- Nicotine pouches: Not covered by TPD. Regulated at the member state level with significant variation.
- Recommended nicotine grade: EP-compliant material simplifies notifications
Plan for the 6-month notification lead time. It catches manufacturers off guard more often than the technical requirements do.
United Kingdom: TPD With Divergence
The UK adopted EU TPD rules into domestic law post-Brexit but is charting its own course.
- Current rules: Mirror TPD. 20 mg/mL limit, notification process intact.
- Nicotine pouches: Not classified as tobacco products. Subject to general product safety rules only.
- Regulatory direction: The UK government has positioned vaping as a smoking cessation tool, signaling a more permissive approach.
- MHRA pathway: Nicotine vaping products can be licensed as medicines through the Medicines and Healthcare products Regulatory Agency.
UK market entry is straightforward if you're already TPD-compliant. Watch for divergence as the UK builds its independent framework.
Canada: Tightening Controls
The Tobacco and Vaping Products Act (TVPA) governs the market.
- Nicotine limit: 20 mg/mL (reduced from 66 mg/mL in 2021)
- Flavor restrictions: Only tobacco, mint, and menthol permitted in vaping products
- Reporting: Product notification and annual reporting required
- Nicotine pouches: Regulated as natural health products (NHP) requiring a product license
The flavor restriction dramatically narrows the addressable market. The NHP pathway for pouches adds 6-12 months of regulatory work.
Australia: Prescription-Only
Australia took the most restrictive approach of any major English-speaking market.
- Classification: Nicotine vaping products are prescription medicines since October 2021
- Consumer access: Valid prescription required for purchase
- Import controls: Personal importation limited to 3-month supply with prescription
- Nicotine pouches: Schedule 4 poisons. Prescription required.
Pharmaceutical-grade nicotine with complete TGA-compliant documentation is non-negotiable here. This market demands the highest quality standards of any country on this list.
Japan: Heated Tobacco Dominates
Japan's regulatory structure created a unique market dynamic.
- Heated tobacco: Legal and popular (IQOS, Ploom, glo). Regulated under the Tobacco Business Act.
- Nicotine e-liquids: Classified as pharmaceutical products. Effectively banned without drug approval.
- Non-nicotine e-liquids: Unregulated.
- Nicotine pouches: Emerging market, regulatory status evolving.
If you're targeting Japan, heated tobacco products are the realistic pathway. The e-liquid market is effectively closed to nicotine products.
India: Manufacturing Hub, Not Consumer Market
- E-cigarettes: Banned under the Prohibition of Electronic Cigarettes Act (2019)
- Heated tobacco: Legal gray area with regulatory uncertainty
- Nicotine for export: India is a major manufacturing hub. Export production is permitted.
- Nicotine pouches: Regulatory status varies by state
India matters as a supply source, not a consumer market for finished nicotine products.
Building a Multi-Market Strategy
Three principles hold true across every market on this list:
Start with dual-compliant nicotine. USP/EP-grade material with full COAs covers the broadest range of regulatory requirements. It's cheaper to source one high-quality grade than to manage separate supply chains for each market.
Let the strictest market set your floor. If you're selling in both the US and EU, build your documentation to PMTA standards. Everything else becomes a subset.
Choose a supplier who knows multiple frameworks. NicAlliance provides market-specific documentation for every major regulatory framework. One supplier relationship, complete coverage across your target markets.
Regulations shift fast. What we've outlined here reflects the landscape as of early 2026. Contact us for current documentation packages tailored to your specific target markets.
If this was useful, there's more where it came from.
Industry intelligence for nicotine product manufacturers. No fluff.